Score:
5.5/10
Analyze what earned this score 🔥
Topper’s Copy
GS3
Science & Technology
10 marks
Neglected Tropical Diseases (NTDs) expose the deep inequities in global healthcare governance and vaccine research.
In the light of the recent Bundibugyo ebolavirus outbreak, discuss the challenges in vaccine development for NTDs and examine the measures needed to strengthen global health preparedness.
Student’s Answer
Evaluation by SuperKalam
Demand of the Question
- Discuss challenges in vaccine development for NTDs (using Bundibugyo outbreak as context)
- Examine measures needed to strengthen global health preparedness
- Address healthcare governance inequities exposed by NTDs
- Forward-looking perspective on strengthening systems
What you wrote:
The 2026 Bundibugyo Ebola Virus Disease (BVD) outbreak in the democratic Republic of Congo (DRC) and Uganda, declared a Public Health emergency of International Concern (PHEIC) by the World Health Organization, exposed persistent gaps in health equity and global vaccine governance. Notably, no licensed vaccine currently exists for the Bundibugyo strain.
The 2026 Bundibugyo Ebola Virus Disease (BVD) outbreak in the democratic Republic of Congo (DRC) and Uganda, declared a Public Health emergency of International Concern (PHEIC) by the World Health Organization, exposed persistent gaps in health equity and global vaccine governance. Notably, no licensed vaccine currently exists for the Bundibugyo strain.
Suggestions to improve:
- Could briefly define NTDs to establish broader context (e.g., "NTDs affect over **1.7 billion people globally**, predominantly in low-income regions").
What you wrote:
Challenges in Vaccine Development
* Market failure: NTDs affect poorer populations, offering limited commercial incentives.
* R&D inequality: Global research funding remains concentrated on high-income country diseases.
* Pathogen diversity: Existing Ebola vaccines mainly target the Zaire strain, leaving Bundibugyo inadequately covered.
* Weak health systems: Limited clinical-trial infrastructure, surveillance and manufacturing capacity in endemic regions.
* Vaccine inequity: Dependence on a few countries for technology and production.
Challenges in Vaccine Development
* Market failure: NTDs affect poorer populations, offering limited commercial incentives.
* R&D inequality: Global research funding remains concentrated on high-income country diseases.
* Pathogen diversity: Existing Ebola vaccines mainly target the Zaire strain, leaving Bundibugyo inadequately covered.
* Weak health systems: Limited clinical-trial infrastructure, surveillance and manufacturing capacity in endemic regions.
* Vaccine inequity: Dependence on a few countries for technology and production.
Suggestions to improve:
- Could expand on regulatory hurdles (e.g., "**Complex approval processes** requiring separate trials for each strain, with limited harmonization between regulatory agencies")
- Can include funding statistics (e.g., "Only **1% of new medicines** developed between 1975-2004 targeted NTDs despite affecting 12% of global population")
What you wrote:
Measures Needed
* Strengthen WHO Pandemic Fund and global financing mechanisms.
* Accelerate the 100 Days Mission for rapid vaccine development.
* Promote technology transfer and regional vaccine manufacturing hubs in Africa and Asia.
* Expand genomic surveillance, early warning systems and cross border cooperation.
* Operationalise the One Health Approach and treat vaccines as Global Public Goods.
Measures Needed
* Strengthen WHO Pandemic Fund and global financing mechanisms.
* Accelerate the 100 Days Mission for rapid vaccine development.
* Promote technology transfer and regional vaccine manufacturing hubs in Africa and Asia.
* Expand genomic surveillance, early warning systems and cross border cooperation.
* Operationalise the One Health Approach and treat vaccines as Global Public Goods.
Suggestions to improve:
- Could highlight successful models (e.g., "**Partnership for African Vaccine Manufacturing Initiative (PAVMI)** aims to establish manufacturing capacity across Africa")
- Can elaborate on governance reforms (e.g., "Strengthening **WHO's authority** in coordinating global vaccine allocation and establishing binding international health regulations")
What you wrote:
→ With over 1000 suspected cases reported in the 2026 outbreak, the crisis shows that global health security is only as strong as its weakest health system. Building resilient health systems, ensuring vaccine justice and strengthening pandemic preparedness are essential for achieving SDG-3.
→ With over 1000 suspected cases reported in the 2026 outbreak, the crisis shows that global health security is only as strong as its weakest health system. Building resilient health systems, ensuring vaccine justice and strengthening pandemic preparedness are essential for achieving SDG-3.
Suggestions to improve:
- Could reference specific timeline goals (e.g., "Achieving **pandemic preparedness targets by 2030** requires immediate action on vaccine equity and manufacturing capacity").
Your answer demonstrates strong awareness of current developments and addresses key challenges systematically. The structure is clear and you've effectively used the Bundibugyo outbreak as a lens to examine broader NTD vaccine challenges. Consider adding more specific examples and elaborating on governance mechanisms to strengthen the response further.
Demand of the Question
- Discuss challenges in vaccine development for NTDs (using Bundibugyo outbreak as context)
- Examine measures needed to strengthen global health preparedness
- Address healthcare governance inequities exposed by NTDs
- Forward-looking perspective on strengthening systems
What you wrote:
The 2026 Bundibugyo Ebola Virus Disease (BVD) outbreak in the democratic Republic of Congo (DRC) and Uganda, declared a Public Health emergency of International Concern (PHEIC) by the World Health Organization, exposed persistent gaps in health equity and global vaccine governance. Notably, no licensed vaccine currently exists for the Bundibugyo strain.
The 2026 Bundibugyo Ebola Virus Disease (BVD) outbreak in the democratic Republic of Congo (DRC) and Uganda, declared a Public Health emergency of International Concern (PHEIC) by the World Health Organization, exposed persistent gaps in health equity and global vaccine governance. Notably, no licensed vaccine currently exists for the Bundibugyo strain.
Suggestions to improve:
- Could briefly define NTDs to establish broader context (e.g., "NTDs affect over **1.7 billion people globally**, predominantly in low-income regions").
More Challenges
View All- View Challenge
GS2
International Relations
14 Aug, 2026
Power trade is emerging as an important instrument of India’s neighbourhood diplomacy. Examine how electricity cooperation with Bangladesh, Nepal and Bhutan can advance India’s strategic and economic interests while promoting regional integration.
- View Challenge
GS2
Indian Polity
Yesterday
The FCRA Amendment Bill, 2026 seeks to strengthen state oversight over foreign-funded organisations while raising concerns about civil society autonomy. Critically examine.
- View Challenge
GS3
Economy
12 Aug, 2026
The next phase of India's MSME growth lies not merely in creating more enterprises, but in clustering them. Examine how a cluster-based approach can enhance the productivity and global competitiveness of Indian MSMEs.
SuperKalam is your personal mentor for UPSC preparation, guiding you at every step of the exam journey.
Download the App
STUDY RESOURCES
CONTACT US
ⓒ Snapstack Technologies Private Limited